Related Experiment Video
Updated: May 19, 2026

06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Low CD4/CD8 Ratio in Bronchus-Associated Lymphoid Tissue Is Associated with Lung Allograft Rejection
K V Shenoy1, C Solomides, F Cordova
1Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Journal of Transplantation
|August 29, 2012
Summary
Bronchus-associated lymphoid tissue (BALT) presence correlates with increased lung transplant rejection episodes within the first year. A lower CD4/CD8 ratio also predicts more frequent acute cellular rejection after lung transplantation.
Area of Science:
- Immunology
- Transplantation immunology
- Pulmonary medicine
Background:
- Bronchus-associated lymphoid tissue (BALT) is implicated in rat lung allograft rejection.
- Previous studies have not linked BALT to significant rejection in human recipients.
- This study investigates the relationship between BALT composition and acute lung allograft rejection.
Purpose of the Study:
- To determine if the immunohistochemical composition of BALT varies with acute lung allograft rejection.
- To explore the association between BALT and rejection frequency/severity in human lung transplant recipients.
Main Methods:
- Retrospective analysis of 40 human lung allograft recipients.
- Classification of patients based on acute rejection frequency and severity (ISHLT criteria).
- Immunohistochemical staining of BALT for T- and B-cell subpopulations in transbronchial biopsies.
Main Results:
- BALT presence was associated with a higher frequency of acute rejection episodes in the first year post-transplant.
- A lower CD4/CD8 ratio correlated with an increased rate of rejection.
- BALT size and T/B-cell densities did not show a correlation with rejection rates.
Conclusions:
- The presence of BALT is linked to increased lung allograft rejection frequency within one year.
- A lower CD4/CD8 ratio is a predictor of acute rejection episodes.
- BALT's immunohistochemical profile may help identify patients at risk for frequent acute cellular rejection.

